A Phase 1, Open-Label, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ES-481 After Oral Administration in Healthy Volunteers. - Niecestro R; Foster EC; Millist L; Germaine J; Niecestro A; O'Brien TJ (European journal of drug metabolism and pharmacokinetics, 2026)